Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a CGM to market.

A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not ... for one two-week sensor and £300 for four. There are more than 25 million type ...

We recently published a list of 10 Best Growth Stocks Under $100 to Buy Now. In this article, we are going to take a look at ...

The FDA cited issues with DexCom’s response to prior inspection findings, known as Form 483 observations. The inspections took place at the San Diego facility between October 21 and November 7, 2024, ...

DexCom, Inc. (NASDAQ ... systems for people with diabetes. Its CGM devices provide real-time glucose readings through a sensor, transmitter, and mobile app, eliminating the need for traditional ...

Savefor later Page saved! You can go back to this later in your Diabetes and Me Close ...

March 7 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab said it has received a warning letter from the U.S. Food and Drug Administration following inspections of its two key ...

DexCom DXCM0.71%increase; green up pointing triangle received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz. facilities and is ...

Impact and progress Frontiers' impact Progress Report 2022 All annual reports ...